Hsbc Holdings PLC Emergent Bio Solutions Inc. Transaction History
Hsbc Holdings PLC
- $160 Billion
- Q2 2024
A detailed history of Hsbc Holdings PLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 87,679 shares of EBS stock, worth $656,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,679
Previous 64,429
36.09%
Holding current value
$656,715
Previous $163,000
266.26%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding EBS
# of Institutions
154Shares Held
30.2MCall Options Held
137KPut Options Held
706K-
Black Rock Inc. New York, NY3.84MShares$28.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$27.5 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.17MShares$23.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.24MShares$9.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny946KShares$7.09 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $373M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...